These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15021837)

  • 1. Presentation of donor major histocompatibility complex class II antigens by dna vaccination prolongs heart allograft survival.
    Pêche H; van Denderen B; Roussel JC; Trinité B; Soulillou JP; Cuturi MC
    Transplantation; 2004 Mar; 77(5):733-40. PubMed ID: 15021837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-beta1 and donor dendritic cells are common key components in donor-specific blood transfusion and anti-class II heart graft enhancement, whereas tolerance induction also required inflammatory cytokines down-regulation.
    Gagne K; Brouard S; Guillet M; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 Oct; 31(10):3111-20. PubMed ID: 11592088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presentation of donor major histocompatibility complex antigens by bone marrow dendritic cell-derived exosomes modulates allograft rejection.
    Pêche H; Heslan M; Usal C; Amigorena S; Cuturi MC
    Transplantation; 2003 Nov; 76(10):1503-10. PubMed ID: 14657694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decreased anti-donor major histocompatibility complex class I and increased class II alloantibody response in allograft tolerance in adult rats.
    Cuturi MC; Josien R; Cantarovich D; Bugeon L; Anegon I; Menoret S; Smit H; Douillard P; Soulillou JP
    Eur J Immunol; 1994 Jul; 24(7):1627-31. PubMed ID: 8026523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MHC class II presenting cells are necessary for the induction of intrathymic tolerance.
    Goss JA; Nakafusa Y; Flye MW
    Ann Surg; 1993 May; 217(5):492-9; discussion 499-501. PubMed ID: 8489312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and humoral mechanisms of vascularized allograft rejection induced by indirect recognition of donor MHC allopeptides.
    Vella JP; Magee C; Vos L; Womer K; Rennke H; Carpenter CB; Hancock W; Sayegh MH
    Transplantation; 1999 Jun; 67(12):1523-32. PubMed ID: 10401758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of recombinant interferon gamma and interleukin-2 and of a monoclonal antibody against interferon gamma on the rat immune response against heart allografts.
    Paineau J; Priestley C; Fabre J; Chevalier S; van der Meide P; Schellekens H; Jacques Y; Soulillou JP
    J Heart Lung Transplant; 1991; 10(3):424-30. PubMed ID: 1906747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgM and IgG alloantibody responses to MHC class I and II following rat renal allograft rejection. Effects of transplantectomy and posttransplantation blood transfusion.
    Wray DW; Baldwin WM; Sanfilippo F
    Transplantation; 1992 Jan; 53(1):167-74. PubMed ID: 1370736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart allograft survival in rats following immunization with soluble peptide MHC class I donor antigens: evidence for the role of indirect recognition in rejection.
    Terness P; Dufter C; Post S; Thies J; Otto G; Koru T; Opelz G
    Transpl Int; 1994; 7 Suppl 1():S584-5. PubMed ID: 11271314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of tolerance to an experimental cardiac allograft through intrathymic inoculation of class II major histocompatibility complex disparate antigens.
    Shen Z; Mohiuddin M; Yokoyama H; Reiss GR; DiSesa VJ
    J Thorac Cardiovasc Surg; 1996 Nov; 112(5):1315-8. PubMed ID: 8911329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistence of Th1- and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance.
    Krieger NR; Most D; Bromberg JS; Holm B; Huie P; Sibley RK; Dafoe DC; Alfrey EJ
    Transplantation; 1996 Nov; 62(9):1285-92. PubMed ID: 8932273
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-TNF antibody modulates cytokine and MHC expression in cardiac allografts.
    Wei RQ; Schwartz CF; Lin H; Chen GH; Bolling SF
    J Surg Res; 1999 Feb; 81(2):123-8. PubMed ID: 9927530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of immunodominant donor MHC peptides following rejection and donor strain transfusion-induced tolerance of heart allografts in adult rats.
    van Denderen B; Pêche H; Gagne K; Usal C; Cuturi MC; Soulillou JP
    Eur J Immunol; 2001 May; 31(5):1333-9. PubMed ID: 11465090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative studies of specific acquired systemic tolerance induced by intrathymic inoculation of a single synthetic Wistar-Furth (RT1U) allo-MHC class I (RT1.AU) peptide or WAG (RT1U)-derived class I peptide.
    Chowdhury NC; Saborio DV; Garrovillo M; Chandraker A; Magee CC; Waaga AM; Sayegh MH; Jin MX; Oluwole SF
    Transplantation; 1998 Oct; 66(8):1059-66. PubMed ID: 9808492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of chronic renal allograft injury by injection of a monoclonal antibody against a donor MHC Ib molecule in a nude rat model.
    Koch M; Broecker V; Heratizadeh A; Doege C; Strehlau J; Mengel M; Nashan B
    Transpl Immunol; 2008 Jul; 19(3-4):187-91. PubMed ID: 18595711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-TCR Vbeta-specific DNA vaccination prolongs heart allograft survival in adult rats.
    Vignes C; Chiffoleau E; Brouard S; Douillard P; Coudreuse D; Soulillou JP; Cuturi MC
    Eur J Immunol; 2000 Sep; 30(9):2460-4. PubMed ID: 11009077
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-TCR-specific DNA vaccination demonstrates a role for a CD8+ T cell clone in the induction of allograft tolerance by donor-specific blood transfusion.
    Vignes C; Chiffoleau E; Douillard P; Josien R; Pêche H; Heslan JM; Usal C; Soulillou JP; Cuturi MC
    J Immunol; 2000 Jul; 165(1):96-101. PubMed ID: 10861040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allograft survival following immunization with membrane-bound or soluble peptide MHC class I donor antigens: factors relevant for the induction of rejection by indirect recognition.
    Terness P; Dufter C; Otto G; Opelz G
    Transpl Int; 1996; 9(1):2-8. PubMed ID: 8748404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptides derived from alpha-helices of allogeneic class I major histocompatibility complex antigens are potent inducers of CD4+ and CD8+ T cell and B cell responses after cardiac allograft rejection.
    Shirwan H; Leamer M; Wang HK; Makowka L; Cramer DV
    Transplantation; 1995 Feb; 59(3):401-10. PubMed ID: 7871571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of enhancement of renal allograft survival by donor-specific blood transfusion with host MHC-linked inhibition of IgG anti-donor class I alloantibody responses.
    Wasowska B; Baldwin WM; Howell DN; Sanfilippo F
    Transplantation; 1993 Sep; 56(3):672-80. PubMed ID: 7692630
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.